These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1661573)

  • 1. [Chromosomal resistance of plague agent to quinolones].
    Kasatkina IV; Shcherbaniuk AI; Makarovskaia LN; Padeĭskaia EN
    Antibiot Khimioter; 1991 Aug; 36(8):35-7. PubMed ID: 1661573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Virulence of rifampicin and quinolone resistant mutants of strains of plague microbe with Fra+ and Fra- phenotypes].
    Ryzhko IV; Shcherbaniuk AI; Samokhodkina ED; Tsuraeva RI; Mishn'kin BN; Kasatkina IV; Zhigalova TA
    Antibiot Khimioter; 1994 Apr; 39(4):32-6. PubMed ID: 7826172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Formation of virulent antigen-modified mutants (Fra-, Fra-Tox-) of plague bacteria resistant to rifampicin and quinolones].
    Ryzhko IV; Shcherbaniuk AI; Skalyga EIu; Tsuraeva RI; Moldavan IA
    Antibiot Khimioter; 2003; 48(4):19-23. PubMed ID: 13677133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lack of levofloxacin and moxyfloxacin efficacy in experimental plague of albino mice infected with nalidixic acid resistant pathogen (Nal(r))].
    Ryzhko IV; Trishina AV; Verkina LM
    Antibiot Khimioter; 2010; 55(11-12):22-4. PubMed ID: 21574421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effectiveness of new quinolones in experimental aerogenic plague infection of albino mice].
    Shcherbaniuk AI; Lozovoĭ NV; Kasatkina IV; Pasiukov VV
    Antibiot Khimioter; 1994 Jun; 39(6):13-4. PubMed ID: 7847999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibiotics of the aminoglycoside group (gentamicin, sisomicin and amikacin) in the prevention and treatment of experimental plague].
    Shcherbaniuk AI; Makarovskaia LN; Bugaeva OK; Kasatkina IV
    Antibiot Khimioter; 1992 May; 37(5):30-1. PubMed ID: 1417325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of resistance selection and mutant growth fitness on the relative efficacies of streptomycin and levofloxacin for plague therapy.
    Louie A; Deziel MR; Liu W; Drusano GL
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2661-7. PubMed ID: 17517837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Isepamycin in prophylaxis and treatment of experimental plague due to FI+ and FI- variants of plague microbe].
    Smorodinova IuV; Shcherbaniuk AI; Ryzhko IV; Moldavan IA
    Antibiot Khimioter; 2005; 50(8-9):23-6. PubMed ID: 17016907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Beta-lactam antibiotics (ampicillin, cefotaxime) in prevention of experimental plague in albino mice, caused by non-fractioned strains of the pathogen].
    Samokhodkina ED; Ryzhko IV; Tsuraeva RI; Pasiukov VV
    Antibiot Khimioter; 1994 Jul; 39(7):20-3. PubMed ID: 7840704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of trimethoprim sensitivity in strains of Yersinia pestis isolated from various natural foci of plague].
    Kravchenko AN; Mishan'kin BN
    Antibiot Khimioter; 1989 Jan; 34(1):42-6. PubMed ID: 2730213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A comparative study of fluoroquinolones and 3rd-generation cephalosporins in the prevention and treatment of experimental plague caused by Yersinia pestis strains typical and serologically atypical with respect to F1].
    Ryzhko IV; Shcherbaniuk AI; Tsuraeva RI; Samokhodkina ED; Kasatkina IV; Tsetskhladze NS; Pasiukov VV; Roshchina NV
    Antibiot Khimioter; 1997; 42(1):12-6. PubMed ID: 9221699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mice naturally resistant to Yersinia pestis Delta pgm strains commonly used in pathogenicity studies.
    Congleton YH; Wulff CR; Kerschen EJ; Straley SC
    Infect Immun; 2006 Nov; 74(11):6501-4. PubMed ID: 16954401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug resistance in Yersinia pestis mediated by a transferable plasmid.
    Galimand M; Guiyoule A; Gerbaud G; Rasoamanana B; Chanteau S; Carniel E; Courvalin P
    N Engl J Med; 1997 Sep; 337(10):677-80. PubMed ID: 9278464
    [No Abstract]   [Full Text] [Related]  

  • 14. [The sensitivity of plague agent from Siberian natural focuses of disease to antibacterial preparations in vitro].
    Balakhonov SV; Bel'kova SA; Tokmakova EG; Khvoĭnova IG; Zakhlebnaia OD
    Klin Lab Diagn; 2013 Apr; (4):36-40. PubMed ID: 23984554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ofloxacin efficacy in the prophylaxis and treatment of experimental plague due to antigen complete and defective strains of the pathogen].
    Samokhodkina ED; Shcherbaniuk AI; Ryzhko IV; Tsuraeva RI; Skalyga EIu
    Antibiot Khimioter; 2002; 47(3):26-9. PubMed ID: 16127904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cefoperazone in the prevention and treatment of experimental plague caused by typical and fraction-free pathogen strains in white mice].
    Pasiukov VV; Ryzhko IV; Tsuraeva RI; Samokhodkina ED; Roshchina NV
    Antibiot Khimioter; 1994 Aug; 39(8):37-40. PubMed ID: 7695439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness of the new quinolones, ciprofloxacin and pefloxacin in experimental plague].
    Kasatkina IV; Sherbaniuk AI; Makarovskaia LN; Padeĭskaia EN
    Antibiot Khimioter; 1993 Jan; 38(1):42-5. PubMed ID: 8060184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Doxycycline in the prevention of experimental plague induced by plague microbe variants].
    Samokhodkina ED; Ryzhko IV; Shcherbaniuk AI; Kasatkina IV; Tsuraeva RI; Zhigalova TA
    Antibiot Khimioter; 1992 Nov; 37(11):26-8. PubMed ID: 1300930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ceftriaxone in prevention and treatment of experimental plague infection].
    Ryzhko IV; Samokhodkina ED; Zhigalova TA
    Antibiot Khimioter; 1993 Jan; 38(1):39-42. PubMed ID: 8060183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thymidine phosphorylase activity and its relationship to trimethoprim in initial strains and thymidine-, thymine-dependent and trimethoprim-resistant mutants of plague microbe].
    Kravchenko AN; Mishan'kin BN
    Antibiot Khimioter; 1992 Jan; 37(1):17-20. PubMed ID: 1530352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.